| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 60.171 | 118.444 | 104.783 | 115.530 |
| Total Income - EUR | - | - | - | - | - | - | 60.185 | 118.781 | 105.661 | 115.530 |
| Total Expenses - EUR | - | - | - | - | - | - | 71.416 | 107.257 | 91.527 | 91.796 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -11.231 | 11.524 | 14.134 | 23.734 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -11.853 | 10.490 | 13.107 | 21.720 |
| Employees | - | - | - | - | - | - | 4 | 6 | 6 | 5 |
Check the financial reports for the company - Hypenosis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 10.976 | 36.461 | 24.200 | 19.461 |
| Current Assets | - | - | - | - | - | - | 33.529 | 17.674 | 25.647 | 41.623 |
| Inventories | - | - | - | - | - | - | 12.653 | 3.862 | 11.472 | 19.292 |
| Receivables | - | - | - | - | - | - | 7.808 | 4.779 | 7.437 | 9.759 |
| Cash | - | - | - | - | - | - | 13.069 | 9.033 | 6.738 | 12.571 |
| Shareholders Funds | - | - | - | - | - | - | -14.675 | -4.430 | 8.690 | 30.362 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 59.180 | 58.565 | 41.156 | 30.722 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9621 - 9621" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Hypenosis S.r.l.